Sakditad Saowapa/X
Jun 23, 2025, 06:51
Sakditad Saowapa: Excited to Share Our Work at ISTH 2025
Sakditad Saowapa, Oncologist at UI Holden Comprehensive Cancer Center, shared a post on X:
“Excited to share our work at International Society on Thrombosis and Haemostasis (ISTH) in Washington, DC!
Poster PB0518. Thrombotic Outcomes in Pancreatic Cancer Patients on Pembrolizumab vs. Erlotinib. Our real-world data shows pembrolizumab is associated with lower risks of acute DVT and all-cause mortality.
If you’re around, come by and let’s talk immunotherapy, thrombosis, and pancreatic cancer!”
More posts featuring Sakditad “Tew” Saowapa.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 23, 2025, 08:55
Jun 23, 2025, 08:55
Jun 23, 2025, 07:59